Company OverviewProducts & ServicesInvestor Relations
Leadership
Board of Directors
Code of Ethics
Catasys Health
Treatment Programs
Treatment Providers
Annual Reports
SEC Filings
Stock Quote
Stock Chart
Press Releases
Corporate Presentation
Media Resources
IR Contact
Completed Studies
Program Facts
 
Picture2
 

Completed Studies
  On the Web
Clinical Study of the Prometa Treatment Program for Alcohol Dependence at the Medical University of South Carolina (MUSC), Charleston, SC
Raymond F. Anton, MD; Hugh Myrick, MD;  Alicia M. Baros, PhD; Patricia K. Latham, PhD; Patrick K. Randall, PhD; Tara M. Wright, MD;  Scott H. Stewart, MD; Randy Waid, PhD; and Robert Malcolm, MD
> 60-subject, double-blind, placebo-controlled study
> Percent days abstinent and time to first heavy drinking day as primary endpoints
Study published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.
   
Clinical Study of the Prometa Treatment Program for Methamphetamine Dependent Subjects at Research Across America, Dallas, TX
Harold C. Urschel III, MD, MMA; Larry L. Hanselka, PhD; Michael Baron, PhD
> 135-subject, double-blind, placebo-controlled study
> Craving, drug use, and the correlation between the two as endpoints
Study published in the Journal of Psychopharmacology, November 25, 2009.
   
An Open-label Study on the Safety and Clinical Effectiveness of the Prometa Treatment Program in Treating Methamphetamine Dependence at Research Across America, Dallas, TX
Harold C. Urschel III, MD, MMA;  Larry L. Hanselka, PhD; Irina Gromov, MD, PhD; Lenae White, MD; Michael Baron, PhD
> 50-subject open-label study
> Craving, number of days abstinent as endpoints
Study published in Mayo Clinic Proceedings, October 2007;82(10):1170-1178.
   
Clinical study of the Prometa Treatment Program for alcohol dependence at Institute of Addiction Medicine, Philadelphia, PA
Joseph R. Volpicelli, M.D.; PhD, Emily Loscalzo, MS; Jenny Starosta, PhD; and Domenick Braccia, DO
> 120-subject, randomized, double-blind, placebo-controlled study
> Craving and percent drinking days as endpoints
Study completed and submitted for publication.
 
   
 
   
  Providing specialized behavioral health management services to health plans, employers and unions through a network of licensed and company managed health care providers.
   
  For more info CatasysHealth.com
 
   
   
   
 
 
   
  If you or someone you know has been struggling with substance dependence, it is important to recognize that it involves much more than just behavior. The reality is, physical, psychological, and social factors all contribute to the disease.
   
  For more information on Prometa, visit prometainfo.com
   
     
   
   
 
Home|Contact Us|Careers|Terms of Use
© 2010 Hythiam, Inc. All rights reserved. Hythiam®, the Hythiam® logo, Catasys®, PROMETA®, and the PROMETA® Treatment Program are trademarks of Hythiam®, Inc.